First Report of Drug Resistance against HIV-1 Integrase Inhibitors in Iran
Background: Four Integrase Strand Transfer Inhibitors (INSTIs) have been approved for HIV-1 by the Food and Drug Administration (FDA). Recently, resistance against these INSTIs drugs and cross-resistance among them have been reported. The aim of the current study was to evaluate INSTIs drug resistan...
Main Authors: | Mohammad GHOLAMI, Negin Hosseini ROUZBAHANI, Leila TAJ, Katayoun TAYERI, SeyedAhmad SEYEDALINAGHI, Seyed Ali Dehghan MANSHADI |
---|---|
Format: | Article |
Language: | English |
Published: |
Third Party Medicine International Publishing Group Co. Limited
2019-04-01
|
Series: | Journal of International Translational Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.11910/2227-6394.2019.07.01.05 |
Similar Items
-
The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011) -
Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors
by: Rossana Scutari, et al.
Published: (2020-03-01) -
HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01) -
Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis
by: Jennifer L Elliott, et al.
Published: (2020-09-01) -
Evaluation of the NIH clinical collection to identify potential HIV-1 integrase inhibitors
by: Abrahams, Shaakira
Published: (2014)